Some Patients With Breast Cancer May Safely Avoid Locoregional Irradiation After Neoadjuvant Chemotherapy – The ASCO Post
It may be possible for some patients with breast cancer to avoid adjuvant regional nodal irradiation safely, according to the results of the NRG Oncology/NSABP B-51/RTOG 1304 clinical trial presented at the 2023 San Antonio Breast Cancer Symposium. 1 These findings particularly apply to patients whose breast cancer conve rted from lymph node–positive to lymph node–negative after neoadjuvant chemotherapy. There was no difference in the 5-year rates of disease recurrence or death among patients who had